Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. 2003

Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

In preclinical experiments, the combination of transcutaneous, low-frequency ultrasound and thrombolytic therapy has shown improved patency rates over thrombolytics alone. A total of 25 patients with myocardial infarction were treated with a thrombolytic agent and adjunctive transcutaneous ultrasound. No unanticipated major adverse events were observed.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic

Related Publications

Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
March 1994, Lancet (London, England),
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
December 1984, Journal of UOEH,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
September 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
January 1985, Acute care,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
June 1983, The American surgeon,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
January 1983, Heart & lung : the journal of critical care,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
July 1990, Rinsho byori. The Japanese journal of clinical pathology,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
January 1983, The Nebraska medical journal,
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
January 2001, Heart (British Cardiac Society),
Mauricio G Cohen, and Enrique Tuero, and Jorge Bluguermann, and Rubén Kevorkian, and Daniel H Berrocal, and Oscar Carlevaro, and Eduardo Picabea, and Michael P Hudson, and Robert J Siegel, and Lori Douthat, and Adam B Greenbaum, and Debra Echt, and W Douglas Weaver, and Liliana R Grinfeld
August 2007, Minerva cardioangiologica,
Copied contents to your clipboard!